Intervention not reported
Exacerbations requiring oral corticosteroids3 months · adults or children with asthma
The intervention showed no clear difference in exacerbations requiring oral corticosteroids3 months (low certainty).
1 finding from 1 review
Intervention not reported
Exacerbations requiring hospital admission 6 months · adults or children with asthma
The intervention showed no clear difference in exacerbations requiring hospital admission 6 months (low certainty).
1 finding from 1 review
Intervention not reported
Asthma control (ACQ) Scale 0 to 6; lower is better12 months · adults or children with asthma
1 finding from 1 review
Intervention not reported
Serious adverse events (including mortality) · adults or children with asthma
1 finding from 1 review
Intervention not reported
Asthma‐related quality of life (AQLQ) Scale 1 to 7; higher is better 8 months · adults or children with asthma
1 finding from 1 review
Intervention not reported
Unscheduled healthcare visits 5 months · adults or children with asthma
The intervention showed no clear difference in unscheduled healthcare visits 5 months (low certainty).
1 finding from 1 review
Intervention not reported
Lung function (trough FEV1) · adults or children with asthma
1 finding from 1 review
Six‐minute walk distance · people with ILD
1 finding from 1 review
Endurance shuttle walk test (ESWT) (m) · people with ILD
1 finding from 1 review
no estimate extracted
1 study · 6 participants
Low
Dyspnea · people with ILD
1 finding from 1 review
Endurance time on constant load ergometry (s) · people with ILD
1 finding from 1 review
Intervention not reported
Exacerbations requiring oral corticosteroids 48 weeks · adults with asthma
The intervention showed no clear difference in exacerbations requiring oral corticosteroids 48 weeks (moderate certainty).
1 finding from 1 review
Intervention not reported
Quality of life (AQLQ) · adults with asthma
1 finding from 1 review
Intervention not reported
Serious adverse events 49 weeks · adults with asthma
The intervention showed no clear difference in serious adverse events 49 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Exacerbations requiring hospital admission 49 weeks · adults with asthma
The intervention showed no clear difference in exacerbations requiring hospital admission 49 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Lung function (change in trough FEV1 L) · adults with asthma
1 finding from 1 review
Intervention not reported
Asthma control (ACQ) · adults with asthma
1 finding from 1 review
Intervention not reported
Any adverse events 49 weeks · adults with asthma
The intervention leads to lower any adverse events 49 weeks (high certainty).
1 finding from 1 review
Re‐admission during · Adults with acute asthma
Adults: higher dose/longer course showed no clear difference in re‐admission in compared with lower dose/shorter course (low certainty).
1 finding from 1 review
Exacerbations · Adults with acute asthma
It is very uncertain whether adults: prednisolone changes new exacerbation during compared with dexamethasone (very low certainty).
2 findings from 1 review